Loading...
Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma
Primary effusion lymphoma (PEL) is a highly aggressive B-cell malignancy that is closely associated with one of oncogenic viruses infection, Kaposi's sarcoma-associated herpesvirus (KSHV). PEL prognosis is poor and patients barely survive more than 6 months even following active chemotherapy in...
Na minha lista:
| Udgivet i: | Oncogene |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5578886/ https://ncbi.nlm.nih.gov/pubmed/28459467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2017.122 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|